ORGANIZED BY FUNDACIÓN GECP
|
|
|
- Carmella Ryan
- 5 years ago
- Views:
Transcription
1 ORGANIZED BY FUNDACIÓN GECP
2 Thursday November 22 nd, :00-10:30 Present situation and future: Spanish Lung Cancer Group The SLCG Thoracic Tumor Register (RTT) Dr. Mariano Provencio 10:30-10:50 ASEICA report on lung cancer in Spain Dr. Carlos Camps Hospital General Universitario, Valencia. CIBERONC 10:50-12:00 SESSION I - NSCLC: EARLY STAGES Dr. Manuel Cobo Hospital Universitario Carlos Haya, Málaga Dr. Rosario García-Campelo Complejo Hospitalario Universitario, A Coruña 10:50-11:05 TNM staging for lung cancer and future updates Dr. Antoni Rosell 11:05-11:25 Treating Stage I without surgery: SBRT Dr. Francisco Valcárcel 11:25-11:40 Postoperative chemotherapy Dr. Bartomeu Massutí Hospital General Universitario, Alicante 12:10-13:20 SESSION II - MOLECULAR BIOLOGY OF LUNG CANCER Dr. Carlos Camps Hospital General Universitario, Valencia. CIBERONC Dr. Noemí Reguart Hospital Clinic, Barcelona 12:10-12:15 Liquid biopsy in lung cancer: state of art Dr. Eloisa Jantus Hospital General Universitario, Valencia. CIBERONC 12:15-12:30 Next generation sequencing: how and when in lung cancer care? Dr. Atocha Romero 12:30-12:45 TMB. Practical approach Dr. Fatima Al Shahrour Spanish National Cancer Center (CNIO), Madrid 12:45-13:00 Different approaches for genomic analysis in lung cancer Dra. Clara Mayo Pangaea Oncology, Hospital Universitari Quirón Dexeus, Barcelona 13:00-13:20 Discussion 13:20-14:30 Lunch 11:40-12:00 Joint discussion 12:00-12:10 Break
3 14:30-15:10 SESSION III - CURRENT SPANISH LUNG CANCER GROUP TRIALS Dr. Ernest Nadal ICO, Hospital Durán i Reynals, L Hospitalet de Llobregat (Barcelona) Dr. Dolores Isla Hospital Clínico Universitario Lozano Blesa, Zaragoza 15:10-16:45 SESSION IV - NEW STRATEGIES IN SCLC AND OTHER THORACIC TUMORS Dr. Amelia Insa Hospital General Universitario, Valencia Dr. Manuel Dómine Hospital Universitario Fundación Jiménez Díaz, Madrid 15:10-15:25 Update in SCLC last year Dr. Javier de Castro Hospital Universitario La Paz, Madrid 15:25-15:40 Current role of radiotherapy in SCLC Dr. Antonio Gómez Caamaño Hospital Clínico Universitario de Santiago, Santiago de Compostela 15:40-15:55 Neuroendocrine tumors Dr. José Luis González-Larriba Hospital Clínico San Carlos, Madrid 15:55-16:15 Thymic tumors. New therapies for Malignant Mesothelioma Dr. Jordi Remón HM Delfos, Centro Integral Clara Campal, Barcelona 16:15-16:45 Discussion 16:45-17:00 Coffee Break
4 17:00-18:50 SESSION V - IMMUNOTHERAPY Dr. Carlos Carracedo ALIADAS, Instituto Nacional de Enfermedades Neoplásicas, Lima, Perú Dr. Aylen Vanessa Ospina Asociación Colombiana de Hematología y Oncología (ACHO) 17:00-17:15 Biomarkers in immunotherapy Dr. Joaquim Bosch Instituto Catalán de Oncología, Girona 17:15-17:35 Microbiota and immunotherapy Dr. M. Paula Roberti Institut Gustave Roussy, France 17:35-18:00 Inmunotherapy in first line? Dr. Delvys Rodríguez Abreu Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria 18:00-18:20 Toxicity management of inmuntherapy Dr. Reyes Bernabé Hospital Universitario Virgen del Rocío, Sevilla 18:20-18:50 Discussion Friday November 23 rd, :30-09:30 SLCG Plenary Session 09:30-10:00 Snapshot of concurrent alterations in EGFR, ALK and ROS1 driven NSCLC Dr. Rafael Rosell 10:00-11:00 SESSION VI - LOCALLY ADVANCED DISEASE Dr. Ivana Sullivan Hospital de la Santa Creu i Sant Pau, Barcelona Dr. Pilar Lianes Hospital de Mataró, Mataró (Barcelona) 10:00-10:30 Controversy on the treatment of resectable stage III disease N2 persistent after neadjuvant In favour of surgery: Dr. Florentino Hernando-Trancho Hospital Clínico San Carlos, Madrid Against of surgery: Dr. Joaquín Casal Complejo Hospitalario Universitario de Vigo 10:30-10:45 New agents in locally advanced disease management. Dr. Teresa Morán 10:45-11:00 Discussion 11:00-11:30 Coffee Break
5 11:30-12:35 SESSION VII - CYTOTOXIC CHEMOTHERAPY FOR ADVANCED DISEASE Dr. Luis Paz-Ares Hospital Universitario 12 de octubre, Madrid Dr. Sergio Vázquez Hospital Universitario Lucus Augusti, Lugo 11:30-11:45 Role of chemotherapy in advanced disease: have we reached the bounds? Dr. Antonio Araujo Centro Hospitalar do Porto, Portugal 11:45-12:00 Molecular biology in advanced disease: beyond the targets Dr. Fernando López-Ríos HM Hospitales, Madrid 12:00-12:15 Making decisions in specific subpopulations: elderly and frail patients Dr. José M. Sánchez Hospital Universitario de la Princesa, Madrid 12:15-12:35 Discussion 12:35-13:40 SESSION VIII - LUNG CANCER ONCOGENIC DRIVERS Dr. Josefa Terrasa Hospital Universitario Son Espases, Palma de Mallorca Dr. Alfredo Sánchez Hospital Provincial de Castellón, Castellón 12:35-12:50 EGFR mutations beyond the first line therapy setting Dr. Enriqueta Felip Hospital Universitari Vall d Hebron, Barcelona 12:50-13:05 ALK translocations: can we establish a sequence of drugs? Dr. Enric Carcereny 13:05-13:20 T790M Dr. David Vicente Hospital Universitario Virgen Macarena, Sevilla 13:20-13:40 Discussion 13:40-14:00 Closing remarks
6 ORGANIZING AND SCIENTIFIC COMMITTEE Dr. Mariano Provencio SUPPORTING COMPANIES Platinum: Dr. Carlos Camps Hospital General Universitario, Valencia CIBERONC Dr. Enric Carcereny Dr. Bartomeu Massutí Hospital General Universitario, Alicante Dr. Ernest Nadal ICO, Hospital Durán i Reynals, L Hospitalet de Llobregat (Barcelona) Gold: Dr. Manuel Cobo Hospital General Universitario Carlos Haya, Málaga Dr. Ramón de las Peñas Consorcio Hospital Provincial, Castellón Dr. Manuel Domine Hopital Universitario Fundación Jiménez Díaz, Madrid Dra. María Rosario García Campelo Hospital Teresa Herrera, A Coruña Dr. Jose Luis Gonzalez Larriba Hospital Clínico San Carlos, Madrid Dra. Noemí Reguart Hospital Clinic, Barcelona Dr. Delvys Rodríguez Hospital Insular, Gran Canaria Silver: Bronze: Other Collaborators: Dra. Ivana Gabriela Sullivan Hospital Sant Pau, Barcelona
7 LANGUAGE Lectures will be delivered in English or in Spanish. VENUE Auditorio de la Mutua Madrileña Paseo de Eduardo Dato, Madrid Holding a badge will be required to access the meeting room. CREDITS Activitat acreditada pel Consell Català de la Formació Continuada de les Professions Sanitàries (CCFCPS) Comisión de Formación Continuada del Sistema Nacional de Salud con 1,4 CRÉDITS, expedient núm.: 09/ MD. UNDER THE AUSPICES OF SYMPOSIUM SECRETARIAT Monasterios de Suso y Yuso Madrid (+34) educationalsymposium@doctaforum.com
Gastrointestinal Oncology
2 nd MD ANDERSON INTERNATIONAL MEETING IN Gastrointestinal Oncology CURRENT PRACTICE AND CONTROVERSIES in the Era of Personalized Medicine e Madrid, 13 th -15 th November, 2019 SCIENTIFIC PROGRAM Meeting
PARQUE DE LAS CIENCIAS PROGRAM
15 & 16 September 2016 / Granada, Spain PARQUE DE LAS CIENCIAS PROGRAM International symposium on LIQUID BIOPSIES 2016 will provide a platform for presentations, discussions and planning across all aspect
6 th MD ANDERSON INTERNATIONAL MEETING IN EMBRACING NEW STANDARDS OF CARE IN GYNECOLOGIC CANCERS PRELIMINARY PROGRAM. Meeting Directors:
6 th MD ANDERSON INTERNATIONAL MEETING IN EMBRACING NEW STANDARDS OF CARE IN GYNECOLOGIC CANCERS Madrid, 9 th -11 th May, 2018 PRELIMINARY PROGRAM Meeting Directors: Registrations: www.mdanderson.es/embracingnewstandards
With the Presidency of Her Majesty the Queen Sofia
ay, 21 st 10:00-15:00 Welcome and registration. Posters set-up With the Presidency of Her Majesty the Queen Sofia 12:00-12:15 OFFICIAL OPENING 12:15-13:15 KEYNOTE LECTURE Introduced by: Jesús Ávila. Bengt
6 th MD ANDERSON INTERNATIONAL MEETING IN EMBRACING NEW STANDARDS OF CARE IN GYNECOLOGIC CANCERS PRELIMINARY PROGRAM. Meeting Directors:
6 th MD ANDERSON INTERNATIONAL MEETING IN EMBRACING NEW STANDARDS OF CARE IN GYNECOLOGIC CANCERS Madrid, 9 th -11 th May, 2018 PRELIMINARY PROGRAM Meeting Directors: Registrations: www.mdanderson.es/embracingnewstandards
OVARIAN. CANCER Optimal Therapy. Update ADVANCED. 12 th International Symposium. Valencia, 22 nd February
Organized by Valencia, 22 nd February 2019 12 th International Symposium ADVANCED OVARIAN CANCER Optimal Therapy. Update DIRECTORS Andrés Poveda Initia Oncology, Hospital Quirónsalud, Valencia, Spain Jan
FALL MEETING. Sitges, 7th and 8th October, Venue. ME Sitges Terramar Hotel Passeig Marítim, Sitges, Barcelona
FALL MEETING Sitges, 7th and 8th October, 2018 Venue ME Sitges Terramar Hotel Passeig Marítim, 80 08870 Sitges, Barcelona Sunday 7 th October 2018 Time slot Topic / Title of presentation Chair 9.00 11.00
21-23 CONGRESO INTERNACIONAL DE INVESTIGACIÓN E INNOVACIÓN EN ENFERMEDADES NEURODEGENERATIVAS CONGRESS
IV CONGRESO INTERNACIONAL DE INVESTIGACIÓN E INNOVACIÓN EN ENFERMEDADES NEURODEGENERATIVAS IV INTERNATIONAL ON RESEARCH AND INNOVATION IN IVNEURODEGENERATIVE DISEASES IV CONGRESS ALICANTE 2016 Septiembre
Gastrointestinal Oncology
1stMD ANDERSON INTERNATIONAL MEETING IN Gastrointestinal Oncology CURRENT PRACTICE AND CONTROVERSIES in the Era ra o f Pe Perss on onal aliz ized ed M edicine PRELIMINARY PROGRAM Madrid, 29 November -
II CANCER CELL SIGNALING PATHWAYS CONFERENCE
II CANCER CELL SIGNALING PATHWAYS CONFERENCE AN IN DEPTH LOOK AT LUNG, MELANOMA, GLIOBLASTOMA, BREAST, HEAD & NECK SQUAMOUS CELL CANCERS Fundació Institut d Investigació en Ciències de la Salut Germans
FIRST CANCER CELL SIGNALING PATHWAYS MEETING
FIRST CANCER CELL SIGNALING PATHWAYS MEETING AN IN DEPTH LOOK AT TRENDS IN POLY-TARGETED LUNG CANCER THERAPY Institut Germans Trias i Pujol (IGTP), Conference Meeting Room, Badalona, Barcelona, Spain -
EORTC LUNG CANCER GROUP GROUP MEETING
Sunday 7 th October 2018 Time slot Topic / Title of presentation Chair 9.00 11.00 Board meeting 11.00 11.30 Arrivals & Welcome coffee 11.30 11.50 Welcome & Introduction New Board,, Membership status, Calendar
URO. I International Workshop PEYRONIE S DISEASE UPDATED PATTERNS IN CONSERVATIVE MANAGEMENT AND SURGICAL TREATMENT OF. MADRID, 18th JUNE 2015
I International Workshop UPDATED PATTERNS IN CONSERVATIVE MANAGEMENT AND SURGICAL TREATMENT OF PEYRONIE S DISEASE URO 2015 MADRID, 18th JUNE 2015 Hospital Course Directors: Juan Ignacio Martínez-Salamanca.
April 5-6, 2016 Sabadell, Barcelona
V EDITION OF THE THEORETICAL AND PRACTICAL WORKSHOP FOR V EDITION OF THE THEORETICAL AND PRACTICAL WORKSHOP FOR UPDATE IN ULTRASOUND AND MULTIDISCIPLINARY APPROACH FOR VASCULAR ACCESS April 5-6, 2016 Sabadell,
21-23 ALICANTE INTERNATIONAL CONGRESS ON RESEARCH AND INNOVATION IN NEURODEGENERATIVE DISEASES CONGRESO INTERNACIONAL
IV IV ALICANTE 2016 VENUE: european union intellectual property office Avenida de Europa, 4, E-03008 Alicante, España. INTERNATIONAL CONGRESS ON RESEARCH AND INNOVATION IN NEURODEGENERATIVE DISEASES CONGRESO
LION-HEART. Levosimendan Intermittent administration in Outpatients: effects on Natriuretic peptides in advanced chronic HEART failure
LION-HEART Levosimendan Intermittent administration in Outpatients: effects on Natriuretic peptides in advanced chronic HEART failure Multicentre, randomized, double-blind, parallel group, placebo-controlled
CHAIRMAN. - Hernán Cortés-Funes, Hospital Universitario 12 de Octubre, Instituto de Investigación i+12, Madrid, Spain FACULTY
CHAIRMAN - Hernán Cortés-Funes, Hospital Universitario 12 de Octubre, Instituto de Investigación i+12, Madrid, Spain FACULTY - Alex A. Adjei, Roswell Park Cancer Institute, Buffalo, New York, USA - Emilio
Madrid, 15 th - 16 th November Meeting Venue: Paseo de la Castellana 33, Madrid
Madrid, 15 th - 16 th November 2018 Meeting Venue: Paseo de la Castellana 33, Madrid MORNING (9:00h - 14:00h) Thursday, November 15 th 2018 Low ovarian reserve Chairman: Laura de la Fuente 08:00-08:30
Resultados del estudio Concordance: Relevancia clínica de la determinación del ADNtc mediante la tecnología BEAMing. Ana Vivancos
Resultados del estudio Concordance: Relevancia clínica de la determinación del ADNtc mediante la tecnología BEAMing Ana Vivancos Circulating tumor DNA extended RAS mutational analysis as a surrogate of
Madrid March Manuel Hidalgo. Alberto Bardelli. Lillian Siu. Josep Tabernero. Application deadline February 23 rd
Spanish National Cancer Research Centre CNIO Frontiers Meetings 2015 Madrid 22 25 March 2015 New Trends in Anticancer Drug Development Application deadline February 23 rd Organisers Manuel Hidalgo Alberto
OBJECTIVES OF THE MEETING
OBJECTIVES OF THE MEETING The Second European LAM Conference is an international meeting with the purpose of getting insights into the new results of research and sharing with patient s community and educational
WELCOME. Dear colleagues,
WELCOME Dear colleagues, It is a great pleasure to invite you to take part in the Second Edition of the International Course of Airway and Thoracic Malformations in Paediatrics, to be held on 1-2 October
INTERNATIONAL VIIMEETING OF HIP SURGERY IN YOUNG ADULT
INTERNATIONAL VIIMEETING OF HIP SURGERY IN YOUNG ADULT madrid 22nd-23th march 2012 Course Director MODERATORS AND FACULTY PANNEL R. Larrainzar Hospital U. Infanta Leonor O. Marín Peña Hospital U. Infanta
:00-13:00 Industry Satellite Symposium 1 Room A. 13:00-13:30 Welcome reception Hall 1. 13:30-13:45 Opening and welcome Room B
04-10-2019 12:00-13:00 Industry Satellite Symposium 1 Room A 13:00-13:30 Welcome reception Hall 1 13:30-13:45 Opening and welcome Room B 13:45-14:15 HHH Award lecture Room B 13:45-14:15 HHH Award lecture
BARIATRIC AND METABOLIC SURGERY
WEDNESDAY, OCTOBER 15, 2014 REVISIONAL BARIATRIC SURGERY AND ENDOSCOPY SYMPOSIUM Hospital Clínico San Carlos, Auditorium. Madrid Live Procedures Endoscopic re-sizing of gastro-jejunal anastomosis for dumping
THURSDAY, 9 JUNE 2016
COMMITTEE Dr. Peter Vorwald. Fundación Jiménez Díaz. Madrid. Dr. Gabriel Salcedo. Fundación Jiménez Díaz. Madrid. Dra. María Posada. Fundación Jiménez Díaz. Madrid. Dr. Damián García Olmo. Grupo Quirón
The 2015 Barcelona Congenital Hyperinsulinism Family Conference
The 2015 Barcelona Congenital Hyperinsulinism Family Conference Dra. Paula Casano Sancho Pediatric Endocrinologist Sant Joan de Deu Hospital- U.Barcelona Congenital Hyperinsulinism: Spanish prespective
Dr. Sergi Call Caja Thoracic Surgery Service
Dr. Sergi Call Caja Thoracic Surgery Service Introduction 1. Use of Lymphadenectomy in Lung Metastasectomy? 2. Incidence of lymph node metastases (LNM)? 3. What is the Impact on Survival? Introduction
Complete manuscript title: Brain metastases from lung cancer responding to erlotinib: The importance of EGFR mutation
ERJ Express. Published on July 1, 2010 as doi: 10.1183/09031936.00195609 Complete manuscript title: Brain metastases from lung cancer responding to erlotinib: The importance of EGFR mutation Authors full
5 Courses: 2002, 2004, 2005, 2006 and 2007 Third period: Directors: Carmen Comas-Gabriel and Bernat Serra (Barcelona)
Directors: Dr. Carmen Comas-Gabriel Dr. Bernat Serra Immediate Past Director: Dr. Jose M. Carrera Past Director: Dr. Francisco Gonzalez-Gomez Established: Year 1992 Spanish branch of Ian Donald School
The OncoBEAM RAS liquid biopsy experience in real-world clinical practice Frederick S. Jones, Ph.D., Global Director, Medical Scientific
The OncoBEAM RAS liquid biopsy experience in real-world clinical practice Frederick S. Jones, Ph.D., Global Director, Medical Scientific Affairs,Sysmex 2 OncoBEAM liquid biopsy: circulating tumor DNA (ctdna)
ConsEPOC International Meeting
ConsEPOC International Meeting Hypoxia and Inflammation in Physiology and Disease MADRID, MAY 4 th, 2015 Aula Magna Faculty of Medicine (Universidad Autónoma de Madrid) ArzobispoMorcillo Street 4, Madrid
MUSEC Modular Ultrasound ESTES Course. Manresa, May 30th 2015
MUSEC Modular Ultrasound ESTES Course Manresa, May 30th 2015 2 MUSEC is a course particularly devoted to acute care surgeons that shows ultrasound as a tool for decision-making. MUSEC is a Modular Focused
Articles. Funding Spanish Lung Cancer Group, Roche Farma, Hoffmann-La Roche, and Red Temática de Investigacion Cooperativa en Cancer.
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase
ERJ Express. Published on March 21, 2018 as doi: /
ERJ Express. Published on March 21, 2018 as doi: 10.1183/13993003.02431-2017 Early View Research letter Incidence, predictors and prognostic significance of thromboembolic disease in patients with advanced
Faculty. Silvia Allende, MD Paulina Núñez, MD Raúl Ramírez, MD Gabriel Santiago, MD Nidia Zapata, MD
Justification Breast cancer stands out as the primary cause of death due to tumors in emerging countries where most cases are diagnosed in advanced stages, hindering their successful treatment. In Mexico,
Educating in Radiosurgery Course
www.radiocirugia2012.com Educating in Radiosurgery Course programme Educating in Radiosurgery Course Associates Technical Secretariat: TISA Congresos - Avda. de la Libertad, 17-3 - 20004 DONOSTIA -SAN
ESPNIC Endorsed Advanced Simulation Course. Program
ESPNIC Endorsed Advanced Simulation Course Technological Training Center, La Coruña (Spain), 25 th & 26 th April 2019 Thursday, 25 April 2019 Program Time Activity Instructor/Speaker 8.30-8.45 Presentation,
in combination with cisplatin as first-line doublet 3 as maintenance agent following non-pemetrexed platinum doublet 4
Overall survival (OS) results from PARAMOUNT study of maintenance plus best supportive care (BSC) versus plus BSC, immediately after induction with - Cisplatin, in patients with advanced Nonsquamous Non-small
OBESITY HYPOVENTILATION SYNDROME: CPAP vs NIV. J. F. Masa San Pedro de Alcántara Hospital Cáceres. Spain
OBESITY HYPOVENTILATION SYNDROME: CPAP vs NIV J. F. Masa San Pedro de Alcántara Hospital Cáceres. Spain Hypoventilation mechanisms OHS NIV action CPAP action Mechanical load Leptin resistance Breathing
Academia Pharma Intersect:
The Oncologist Academia Pharma Intersect: Gastrointestinal Cancer First-Line XELOX Plus Bevacizumab Followed by XELOX Plus Bevacizumab or Single-Agent Bevacizumab as Maintenance Therapy in Patients with
MUSEC Modular Ultrasound ESTES Course. Manresa, May 30th 2015
MUSEC Modular Ultrasound ESTES Course Manresa, May 30th 2015 MUSEC is a course particularly devoted to acute care surgeons that shows theultrasound as a tool for decision-making. MUSEC is a Modular Focused
The Oncologist 2018;23:1271 e128 TRIAL INFORMATION LESSONS LEARNED ABSTRACT. Clinical Trial Results
Clinical Trial Results Single-Agent Regorafenib in Metastatic Colorectal Cancer Patients with Any RAS or BRAF Mutation Previously Treated with FOLFOXIRI plus Bevacizumab (PREVIUM Trial) PILAR GARCÍA-ALFONSO,
on Skills Training Workshop in Vascular Access: A Multidisciplinary Approach
VII HANDS-ON HANDS SKILLS TRAINING WORKSHOP IN VASCULAR ACCESS: VI Hands-on on Skills Training Workshop in Vascular Access: A Multidisciplinary Approach May 8-10, 2017 Sabadell, Barcelona With Support
original article introduction article
original article Annals of Oncology 21: 1552 1557, 21 doi:1.193/annonc/mdq47 Published online 15 March 21 Prognostic time dependence of deletions affecting codons 557 and/or 558 of KIT gene for relapse-free
Dra Amanda Iglesias, DUE Rocio Cordova, Hospital Universitario Son Espases-IdISPa,
On-line data supplement Authorship Members of the CHACOS study group Dra Amanda Iglesias, DUE Rocio Cordova, Hospital Universitario Son Espases-IdISPa, CIBERES, Palma de Mallorca, Spain; Dr. Sergi Pascual,
SECOND ANNUAL 3D ADVANCED FIBER DISSECTION COURSE: ACQUIRING THE MENTAL IMAGERY NECESSARY TO OPERATE THE BRAIN Santander, 26 th and 27 th October
SECOND ANNUAL 3D ADVANCED FIBER DISSECTION COURSE: ACQUIRING THE MENTAL IMAGERY NECESSARY TO OPERATE THE BRAIN Santander, 26 th and 27 th October 2018 The white matter of the cerebrum underlies the outer
V Barcelona International Congresson the. Mediterranean. Diet. Preliminar Programme March, 9, 10 and 11, 2004 in: Organized by:
V Barcelona International Congresson the Mediterranean Diet Preliminar Programme March, 9, 10 and 11, 2004 in: Organized by: GOALS andobjectives The healthy benefits of the Mediterranean Diet continue
26 November Lima, Perù
PRELIMINARY PROGRAMME 2014 Pre LACTRIMS conference on progressive MS 26 November 2014 - Lima, Perù Dear participant, A warm welcome to all attending the 2014 Pre LACTRIMS conference on progressive MS.
PRELIMINARY PROGRAMME
Thursday, February 7 th, 2019 08:00 Registration 08:45 Opening A, Artigas, MD (Sabadell, Spain) J. Garnacho, MD (Sevilla, Spain) I. SEPSIS PRELIMINARY PROGRAMME Moderators: A. Artigas, MD (Sabadell, Spain)
INTERNATIONAL SYMPOSIUM
INTERNATIONAL SYMPOSIUM ACTIVE BRAINS FOR ALL: Exercise, cognition and mental health. GRANADA (SPAIN) 12 nd June 2017 PROGRAM INTRODUCTION Brain research is considered one of the key challenges of the
Editorial Manager(tm) for Breast Cancer Research and Treatment Manuscript Draft
Editorial Manager(tm) for Breast Cancer Research and Treatment Manuscript Draft Manuscript Number: Title: Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA mutation carriers. Article Type:
4-6 April 2018 XV UPDATE COURSE IN ANGIOLOGY AND VASCULAR SURGERY I INTERNATIONAL UPDATE COURSE IN ANGIOLOGY AND VASCULAR SURGERY
Course Directors: Valentín Fernández Valenzuela President of the SEACV Jose Daniel Menezes President of the SPACV Manuel Javier Vallina-Victorero Vázquez President of the National Commission Co-Directors:
CLINICAL CHARACTERISTICS AND OUTCOME OF HEART TRANSPLANT IN ADULTS WITH CONGENITAL HEART DISEASES
CLINICAL CHARACTERISTICS AND OUTCOME OF HEART TRANSPLANT IN ADULTS WITH CONGENITAL HEART DISEASES Subanalysis Spanish Registry on Heart TransplantaCon (1984 2010) Authors: Dimpna C. Albert 1 María J. Paniagua
ENYGO REPORT. Summary
ENYGO REPORT Summary The first ENYGO Workshop on Fertility Sparing in Gynaecological Oncology was held at La Paz University Hospital in Madrid (Spain) from 27 to 28 January 2017. It was a very successful
HIV/HCV Coinfection in Spain: elimination is a stone's throw away
HIV/HCV Coinfection in Spain: elimination is a stone's throw away L. Pérez-Latorre 1, J. González 2, M.J. Vivancos 3, J. Navarro 4, M.J. Téllez 5, J.M. Guardiola 6, J.A. Iribarren 7, A. Rivero- Román 8,
PROGNOSTIC FACTORS FOR RELAPSE IN STAGE I SEMINOMA: A NEW NOMOGRAM DERIVED FROM THREE CONSECUTIVE, RISK-ADAPTED STUDIES FROM THE SPANISH
Annals of Oncology Advance Access published September 10, 2014 PROGNOSTIC FACTORS FOR RELAPSE IN STAGE I SEMINOMA: A NEW NOMOGRAM 1 DERIVED FROM THREE CONSECUTIVE, RISK-ADAPTED STUDIES FROM THE SPANISH
Target audience This course is directed to physicians involved in diagnosis and treatment of lysosomal diseases.
18 th UPDATE IN THE MANAGEMENT OF GAUCHER DISEASE AND OTHER LYSOSOMAL DISORDERS. May 13 rd -16 th, 2013. Program goals To provide participants with an update on diagnosis, treatment and management of Gaucher
1st Iberoamerican Congress of Neuropsychology. June 1-4, 2016, 2016 at the Bilbao Exhibition Centre - BEC
WEDNESDAY, JUNE 1 8:30-9:00 Registration Pre-conference workshops 1. Pre-conference workshops 2. Pre-conference workshops 3. Pre-conference workshops 4. 9:00-12:00 Analysis and uses of fmri in Neuropsychology
PROGRAMME April 26 th & 27 th 2019
PROGRAMME April 26 th & 27 th 2019 LIVE SURGERY REJUVENATION WORKSHOPS Dr Ramón Medel IMO barcelonaoculoplastics.com ORGANIZING COMMITTEE Dr Ramón Medel Dr Juan Carlos Sánchez Dr Luz María Vásquez NATIONAL
The Journal of Heart and Lung Transplantation. 2007; 26(11):
The Journal of Heart and Lung Transplantation. 2007; 26(11): 1105-1109 Influence of induction therapy, immunosuppressive regimen and anti-viral prophylaxis on development of lymphomas after heart transplantation:
Chair: W. Eberhardt, DE; S. Peters, CH. 12:00-13:00 Industry Satellite Symposium 1 (TBC) Room A. 13:30-13:45 Opening and Welcome Room B
13-04-2016 12:00-13:00 Industry Satellite Symposium 1 (TBC) Room A 13:30-13:45 Opening and Welcome Room B Chair: W. Eberhardt, DE; S. Peters, CH 13:45-14:15 Heine H. Hansen Award Lecture Room B 14:30-16:00
Instituto Catalàn de Oncología, Hospital German Trias I Pujol, Badalona, Spain 5
Přehledové články First-Line XELOX Plus Bevacizumab Followed by XELOX Plus Bevacizumab or Single-Agent Bevacizumab as Maintenance Therapy in Patients with Metastatic Colorectal Cancer: The Phase III MACRO
Hepatitis C Eradication Reduces Liver Decompensation, HIV progression, and Death in HIV/HCV-coinfected Patients with non-advanced Liver Fibrosis
Hepatitis C Eradication Reduces Liver Decompensation, HIV progression, and Death in HIV/HCV-coinfected Patients with non-advanced Liver Fibrosis J. Berenguer 1, F. X. Zamora 2, C. Díez 1, M. Crespo 3,
VASCULAR ACCESS SYMPOSIUM
3 rd PARC TAULÍ INTERNATIONAL VASCULAR ACCESS SYMPOSIUM October 26-27, 2018 Sabadell, Barcelona SYMPOSIUM INFORMATION Important symposium dates: Online Registration opens July 9, 2018 Symposium Sessions
THE PSA AND PROSTATE CANCER DILEMMA
IV CLINICAL UROLOGY MEETING THE PSA AND PROSTATE CANCER DILEMMA BILBAO February 23-24, 2017 Clínica IMQ Zorrotzaurre Organized by: SOME REASONS TO ATTEND OUR MEETING The PSA test is not a prostate cancer
Occupation-related differences in the prevalence of metabolic syndrome
Diabetes Care Publish Ahead of Print, published online June 20, 2008 Metabolic syndrome in workers Occupation-related differences in the prevalence of metabolic syndrome Miguel Angel Sánchez-Chaparro a,b,
Treating today s patients with tomorrow s solutions
Treating today s patients with tomorrow s solutions 1st conference supported by: European Multidisciplinary Breast Cancer Collaborative (EMBCC) February 5-6, 2016 Maison des oceans Paris EMBCC board members
Resistencias en cáncer de mama HER2 positivo, Hay margen para la mejora?
Resistencias en cáncer de mama HER2 positivo, Hay margen para la mejora? Salamanca, 2018 Un 20% de los tumores son HER2 positivos Alteración molecular fundacional: necesaria, pero no suficiente Cruz JJ,
II Congreso Internacional de Investigación e Innovación en Enfermedades Neurodegenerativas (CIIIEN)
II Congreso Internacional de Investigación e Innovación en Enfermedades Neurodegenerativas (CIIIEN) II International Congress on Research and Innovation in Neurodegenerative Diseases X Simposio Internacional:
Cardiovascular Diseases (BMM9) and Getting to Know CNIC course Course
Cardiovascular Diseases (BMM9) and Getting to Know CNIC course Course 2013-2014 A. Lectures: 13-30 January (09:30-12:15 h) I. Form and function of the cardiovascular system (13-15 January) 13 January (09.30
Wednesday, February 24 th, 2016
List of Faculty: Nadeem R. Abu-Rustum, Giovanni Aletti, Istituto Europeo di Oncologia. Milan, Italy Natalia Carballo, Carlos Centeno, Clínica Universidad de Navarra. Pamplona, Spain David Cibula, General
CHRONIC URTICARIA, STRIVING AND BUILDING FOR EXCELLENCE
CHRONIC URTICARIA, STRIVING AND BUILDING FOR EXCELLENCE BARCELONA 14-15 January 2016 HOSPITAL DEL MAR Passeig Marítim, 25-29 Barcelona 08003 PROGRAM WITH SIMULTANEOUS TRANSLATION Faculty COORDINATORS Giménez-Arnau,
4-6 April 2018 XV UPDATE COURSE IN ANGIOLOGY AND VASCULAR SURGERY I INTERNATIONAL UPDATE COURSE IN ANGIOLOGY AND VASCULAR SURGERY
IN ANGIOLOGY Course Directors: Valentín Fernández Valenzuela President of the SEACV Jose Daniel Menezes President of the SPACV Manuel Javier Vallina-Victorero Vázquez President of the National Commission
Impact of ERBB mutations on clinical outcomes in afatinib- or erlotinib-treated patients with SqCC of the lung
Impact of ERBB mutations on clinical outcomes in afatinib- or erlotinib-treated patients with SqCC of the lung Glenwood D. Goss, Enriqueta Felip, 2 Manuel Cobo, 3 Shun Lu, 4 Konstantinos Syrigos, 5 Ki
Conference Program. STS/EACTS Latin America Cardiovascular Surgery Conference. November 15-17, 2018 Cartagena, Colombia
Conference Program STS/EACTS Latin America Cardiovascular Surgery Conference November 15-17, 2018 Cartagena, Colombia www.cardiovascularsurgeryconference.org info@cardiovascularsurgeryconference.org STS/EACTS
ANONYMOUS UNLINKED STUDY OF THE PREVALENCE OF ANTI- HIV ANTIBODIES IN MOTHERS OF LIVE NEWBORNS FROM 6 AUTONOMOUS REGIONS
SECRETARÍA GENERAL DE SANIDAD DIRECCIÓN GENERAL DE SALUD PÚBLICA Y SANIDAD EXTERIOR ANONYMOUS UNLINKED STUDY OF THE PREVALENCE OF ANTI- HIV ANTIBODIES IN MOTHERS OF LIVE NEWBORNS FROM 6 AUTONOMOUS REGIONS
Workshop: How to tackle the obesity epidemic in European children?
The way to the... Organization: Collaborating entities: Sociedad Argentina de Nutrición Workshop: How to tackle the obesity epidemic in European children? Coordinators: Angel Gil Luis Moreno Mercedes Gil-Campos
This meeting has been made possible by an independent grant from Roche.
This meeting has been made possible by an independent grant from Roche. This event has been created in collaboration between the University of Milan and ecancer. MILAN SUMMIT ON PRECISION MEDICINE AGENDA
Response Predicting Factors to Recombinant Human Erythropoietin in Cancer Patients Undergoing Platinum-Based Chemotherapy
2408 Response Predicting Factors to Recombinant Human Erythropoietin in Cancer Patients Undergoing Platinum-Based Chemotherapy Manolo González-Barón 1 Amdio Ordóñez 1 Rosa Franquesa 2 Manuel Constenla
Clinical. Update in Respiratory Medicine. International Symposium on. Barcelona (Spain) February 23 rd -24 th, 2018 FINAL PROGRAMME
With an unrestricted grant by Organized by Vall d Hebron Barcelona Hospital Campus Barcelona, Spain International FINAL PROGRAMME Respiratory diseases are among the most frequent causes of mortality and
October 12 13, 2018 New York Marriott Marquis New York, New York. The premier conference for annual updates in lung cancer. 23rd Annual Conference
The premier conference for annual updates in lung cancer 23rd Annual Conference October 12 13, 2018 New York Marriott Marquis New York, New York Reserve your place today: thoraciccancermeeting.com Perspectives
Strategies to Reduce Premature Cardiovascular Morbidity and Mortality
Premature Cardiovascular Cartagena de Indias, COLOMBIA, 2018 Congress Venue: Hotel Estelar Cartagena de Indias Organized by: LASH Sociedad Latino Americana de Hipertension Arterial SCCH Sociedad Centroamericana
A. Cano Sanchez J. Calaf i Alsina J.-L. Dueñas-Díez. Selective Estrogen Receptor Modulators. A New Brand of Multitarget Drugs
A. Cano Sanchez J. Calaf i Alsina J.-L. Dueñas-Díez Selective Estrogen Receptor Modulators A New Brand of Multitarget Drugs Antonio Cano Sanchez Joaquim Calaf i Alsina José-Luis Dueñas-Díez (Editors) Selective
The Organizing Committee
Designed by Mar Abril On behalf of the International Society of Chocolate and Cocoa in Medicine (ISCHOM), it is a great pleasure to announce the second International Congress on Chocolate and Cocoa in
III WORKSHOP INTERNATIONAL BIOCAPS 2015 (& 1st Spanish National Symposium in Incretins)
III WORKSHOP INTERNATIONAL BIOCAPS 2015 (& 1st Spanish National Symposium in Incretins) TITLE: DIABESITY new strategic targets and incretins. DATES: 22-24th/OCTOBER/2015. ORGANIZING INSTITUTION: Instituto
Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer
The new england journal of medicine original article Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer Rafael Rosell, M.D., Teresa Moran, M.D., Cristina Queralt, B.S., Rut Porta,
ESMO-Christie Lung Cancer Course
SMO-Christie Lung Cancer Course Wednesday 12th - Friday 14th February 2014 ducation Centre (Dept 17), The Christie, Manchester, M20 4BX This event is a joint initiative between The uropean Society for
ASDEU Final Conference. Aula Pitaluga*, National School of Public Health, Instituto de Salud Carlos III, Madrid, Spain. 29th-30th January 2018
ASDEU Final Conference Aula Pitaluga*, National School of Public Health, Instituto de Salud Carlos III, Madrid, Spain Monday 29th January 29th-30th January 2018 8.30 am - Registrations 9.00-9.10: Welcome
Best of WCLC- San Francisco
Best of WCLC- San Francisco Saturday, November 11, 2017 InterContinental San Francisco UC Davis Comprehensive UCSF Helen Diller Family Comprehensive A B Stanford University Cancer Institute David R. Gandara,
OVERVIEW IN NEUROONCOLOGY. CURRENT STATE IN THE MANAGEMENT OF BRAIN GLIOMAS AND NEW PERSPECTIVES. SECOND EDITION
OVERVIEW IN NEUROONCOLOGY. CURRENT STATE IN THE MANAGEMENT OF BRAIN GLIOMAS AND NEW PERSPECTIVES. SECOND EDITION November 18TH-19TH 2016 Main Auditorium HOSPITAL GENERAL UNIVERSITARIO DE CIUDAD REAL Solicitada
VASCULAR ACCESS SYMPOSIUM
SYMPOSIUM INFORMATION Important symposium dates: Online registration opens June 3, 2013 Abstract submission opens September 1, 2013 Deadline for abstract submission January 19, 2014 Notification of acceptance/rejection
CNIO Friends. CNIO Friends 253. CNIO Friends Postdoctoral Contracts 254. Excelentes : a book of portraits on ideas that drive the world 255
253 Postdoctoral Contracts 254 Excelentes : a book of portraits on ideas that drive the world 255 CNIO opens its doors to 256 Benefactor Friends/Sponsor Friends 258 Donations to the CNIO 259 ANNUAL REPORT
PROGRAMME feb 2019 MADRID COURSE. 7 th MULTIDISCIPLINARY BONE AND SOFT TISSUE TUMORS MADRID COURSE. Dr. E.
PROGRAMME Dr. E. Ortiz Cruz Supported by Musculoskeletal Tumor Society (MSTS) www.bstt-madridcourse.com PRESENTATION We are delighted to announce the organization of the 7th Bone and Soft Tissue Tumors
FEBRUARY 17 TH. NAPLES Hotel Royal Continental. Director: Fortunato Ciardiello 6.6 CME Credits
FEBRUARY 17 TH 2017 NAPLES Hotel Royal Continental Director: 6.6 CME Credits Addressed to The meeting is addressed to oncologists specialized in colorectal cancer. Objectives The therapeutical choice for
4 TH ESO-ESMO LATIN-AMERICAN MASTERCLASS IN CLINICAL ONCOLOGY April 2018 Mexico City, Mexico LATIN-AMERICA PROGRAMME
4 TH ESO-ESMO LATIN-AMERICAN MASTERCLASS IN CLINICAL ONCOLOGY 18-22 April 2018 Mexico City, Mexico Chairs: A. Cervantes, ES - N. Pavlidis, GR R.A. Stahel, CH Scientific Co-ordinators: M. Aapro, CH - F.
DUAL: DarUnavir And Lamivudine
Non-inferiority of dual-therapy with darunavir/ritonavir plus 3TC vs. triple therapy with darunavir/ritonavir plus TDF/FTC or ABC/3TC for maintenance of viral suppression: 48-week results of the DUAL-GESIDA
2 ND TRENDS IN GLAUCOMA
PROGRAM 2 ND TRENDS IN GLAUCOMA INTERNATIONAL MEETING ON NEW IMAGING TECHNOLOGIES, LASERS AND GLAUCOMA SURGERY NOVEMBER 18 TH & 19 TH 2016 INTRODUCTION 2 nd Trends in Glaucoma is an event aimed at glaucomatologists